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Differentiation Among Basal Cell Carcinoma, Benign
Lesions, and Normal Skin Using Electric Impedance
Daryl G. Beetner*, Senior Member, IEEE, Sanat Kapoor, Member, IEEE, Shivappa Manjunath, Xiangyang Zhou,
and William V. Stoecker
Abstract—This paper presents a preliminary study showing the
diagnostic potential of electrical impedance to detect basal cell car-
cinoma (BCC). Electrical impedance was measured in vivo from 1
kHz to 1 MHz on 24 human subjects over BCC (19 lesions), over be-
nign tumors (11 lesions), and over normal skin (all 24 patients). Le-
sions ranged from 2–15 mm in diameter. Indexes based on the mag-
nitude (MIX), phase (PIX), real-part (RIX) and imaginary-part
(IMIX) of impedance were calculated for each measurement. Sig-
nificant differences were found between measurements over BCC,
benign lesions and normal skin for indexes MIX, PIX, and IMIX
(P = 0 04 to P = 7 10 7). Indexes were generally smaller
for measurements of BCC than for benign lesions or normal skin.
Differences were not a result of differences in the patient’s age or
the measurement location. The large size of our measurement elec-
trode (10 mm) probably limited our ability to differentiate lesions
because significant amounts of normal skin were included in each
lesion measurement. A linear regression fit of data with tumor size
suggests that a smaller probe or more sophisticated analysis tech-
niques may improve differentiation. Results suggest that electrical
impedance could be used to provide rapid and noninvasive differ-
entiation of BCC from similar looking benign lesions.
Index Terms—Basal cell carcinoma, bioelectrical impedance,
electric conductivity, spectrum analysis, tissue characterization.
I. INTRODUCTION
BASAL CELL carcinoma (BCC) is the most common malig-nancy. Left untreated, it can cause significant morbidity and
disfigurement and, rarely, death. Fortunately, BCC has a better
than 95% cure rate if detected and treated early. The primary
means of detecting BCC is through visual inspection followed
by biopsy and pathological examination if the physician finds
the lesion suspicious. Unfortunately, not all malignant lesions
are identified through visual inspection. Presently, there are no
generally accepted tools the physician can use to immediately
validate their visual diagnosis in the clinic. An inexpensive, non-
invasive technique that complements information from visual in-
spection could help prevent misdiagnosis of BCC and other types
of skin cancer and would aid early detection and treatment.
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Previous work suggests that electrical impedance may distin-
guish skin cancer from other tissue. The electrical impedance
of a tissue depends on its macro- and micro-structural char-
acteristics as well as its chemical composition. Studies have
shown a wide degree of variation in the bio-electric properties
between tissue types and between tissue states [1]. The changes
that occur with cancer or other diseases manifest themselves
as changes in impedance. Ex vivo studies have shown signifi-
cant differences between the bioimpedance of normal and can-
cerous breast tissue [2]–[4] and between skin cancer and normal
skin [2]. In vivo studies have shown differences in the electrical
impedance of the skin as a result of irritation, allergic reac-
tion (wheals), age, sex, location, and hydration [5]–[9]. A small
clinical study has also shown significant differences between
nodular BCC and normal skin [10].
Most of the in vivo studies of the skin mentioned above used
measurements from an instrument called the impedance spec-
trometer and were based on a comparison of four indexes: mag-
nitude index (MIX), phase index (PIX), real-part index (RIX),





where is the measured impedance at 20 kHz,
is the impedance at 500 kHz.
Emtestam et al. compared measurements of MIX, PIX, RIX,
and IMIX over normal skin and over lesions of nodular BCC
[10]. A total of 12 tumors were studied. Tumors were 10 mm or
more in diameter—the size of the probe electrode used to mea-
sure impedance. Significant differences were found between
values of MIX, and IMIX measured over the tumor and over
normal skin ( ), suggesting that electrical impedance
might be used as a diagnostic tool for BCC.
Our study builds on the study of Emtestam et al. and
compares electrical impedance among normal skin and benign
and malignant lesions of relatively small size. The purpose of
our study is twofold: to show that the results of Emtestam et
al. can be applied clinically to relatively small tumors (less
than 10 mm); and to show the potential of electrical impedance
to differentiate between BCC and benign lesions. Such a
study is useful for future clinical application of electrical
impedance, because the physician would apply techniques to
0018-9294/03$17.00 © 2003 IEEE
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TABLE I
LOCATION OF LESIONS
lesions of small size and would be interested in distinguishing
malignancies from benign tumors.
II. METHODS
Impedance of malignant and benign lesions was measured
prospectively on human patients during a dermatological exam,
following procedures approved by the University of Missouri
Institutional Review Board. Lesions were studied only if they
were marked for removal and biopsy by a dermatologist as part
of the normal course of treatment. A total of 24 patients were
studied, some of whom had multiple lesions. Patients were re-
cruited consecutively and were rejected only for technical rea-
sons, i.e., equipment failure or location of the lesion on a highly
contoured area unsuitable for a 10-mm probe (e.g., the ears and
perinasal areas).
Measurements were made on 19 BCC and 11 benign lesions.
The group with BCC ranged in age from 28 to 85 years with an
average age of 71 years. The group with benign lesions ranged
in age from 39 to 80 years with an average age of 61 years. The
location of lesions is summarized in Table I. Patients were gen-
erally fair-skinned, over 80% Fitzpatrick types I and II. Fitz-
patrick type I skin always burns with sun exposure and Fitz-
patrick type II usually burns with sun exposure. Lesions ranged
in size from 2 mm to 15 mm for BCC and from 2 mm to 10 mm
for benign lesions. The group of benign lesions included two
actinic keratoses, one compound nevus, three intradermal nevi,
one chromoblastomycosis, one cutaneous polyp, one nevus lipo-
matosus, and two seborrheic keratoses. These lesions appeared
consecutively in those who were undergoing biopsy or when the
equipment was available. None of the lesions encountered were
ulcerative or highly keratotic. After impedance measurements
were made, the lesion was shave biopsied and lesion type was
confirmed histologically.
Impedance was measured using the impedance spectrometer
(SciBase AB, Huddinge, Sweden) as in the study by Emtestam
et al. [10]. The spectrometer measures impedance at 31 loga-
rithmically separated frequencies from 1 kHz to 1 MHz. Mea-
surements were made with the hand-held probe shown in Fig. 1.
The probe has four electrodes shaped in a bullseye pattern. The
middle electrode is a sink electrode, the next electrode is a guard
electrode that reduces effects of surface currents and the outer
two electrodes are source electrodes. The outermost electrode
isapproximately 10 mm in diameter. By changing the distribu-
tion of current between the two source electrodes, the position of
a “virtual” electrode between them can be changed. By varying
this position, the spectrometer can measure impedance at five
“depths” ranging from very shallow measurements including
only a superficial portion of the dermis to measurements up to
a few millimeters deep.
Fig. 1. Hand-held probe used to measure impedance.
Fig. 2. (A) Measurements were made with the probe centered on the lesion
(B) with the probe just on the periphery of the lesion and (C) with the probe
placed on normal skin immediately adjacent to the lesion.
Before measuring impedance, the skin was soaked with a
0.9% saline solution for two minutes to increase the conduc-
tivity of the stratum corneum and for 1 min between subsequent
measurements of the same site. Impedance was measured both
on the lesion and on normal skin adjacent to the lesion. The
basic measurement positions are shown in Fig. 2, except that
each off-center measurement was made twice, once on each side
of the lesion. The probe was positioned both over the center
of the lesion and over its periphery in an attempt to obtain at
least one measurement that included the maximum amount of
tissue of interest. When the lesion is small, a good deal of the le-
sion could be “hidden” beneath the center electrode, preventing
the best possible measurement. In that case, an off-center mea-
surement may return better results. Multiple measurements were
made to ensure accuracy. Measurements of adjacent normal skin
were made for comparison. Unrealistic measurements (mea-
surements containing impedance with zero magnitude, change
in sign of phase, sudden and uncharacteristic changes in magni-
tude, etc) were repeated when possible or were discarded [12].
III. RESULTS
Measured values of MIX, PIX, RIX, and IMIX are shown in
Fig. 3. Values are shown over BCC, benign lesions and normal
skin as a function of depth measured by the virtual electrode.
Depth is shown along the axis from the most shallow depth
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Fig. 3. Box and whisker plots for the four indexes at depths 1, 3, and 5. Boxes are partially shaded from dark to light to represent measurements over BCC, benign
lesions, and normal skin, respectively. The line in the middle of each box represents the median value of the data. Boxes extend above and below the median to
include 25% of the measured data points in each direction. Whiskers extend to the minimum and maximum measured value.
TABLE II
MEAN AND STANDARD DEVIATION OF INDEXES AT DEPTHS 1, 3, AND 5
BCC stands for BCC, NOR for normal and BEN for benign.
(D1) of tissue that can be measured by the probe to the deepest
(D5). Measurements at each position are included. Mean and
standard deviation values are summarized in Table II. Statisti-
cally significant differences were estimated using the Wilcoxon
signed rank test. Distributions are significantly different when
the probability of similarity is less than 0.05. Probability of
similarity between distributions at depths 1, 3, and 5 is shown in
TABLE III
PROBABILITY OF SIMILARITY BETWEEN IMPEDANCE MEASURES
Statistical similarity calculated using the Wilcoxon signed rank test. Probability of
similarity less than 0.05 indicates a significant difference.
BCC stands for BCC, NOR for normal and BEN for benign. NS stands for “Not Sig-
nificant”.
Table III. Similar results were found for depths 2 and 4, which
are not shown. Values of MIX, IMIX, and PIX were significantly
lower over BCC than over benign lesions or normal skin for al-
most all measured depths. The exception was depth 5, where
there was no significant difference between BCC and normal
skin. Significant differences generally were not found for RIX.
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Fig. 4. Change of indexes with lesion size. Values of indexes over BCC and benign lesions are marked with light and dark lines, respectively. Index values are
shown on the Y axis. Lesion size is shown on the X axis. Each vertical bar represents the mean value of the index plus or minus one standard-deviation for each
lesion size. The best straight-line approximation of measured values over size was calculated as shown in this graph.
While normal skin generally had a higher index value than be-
nign tissue for MIX, and IMIX, these differences were rarely
significant. Normal skin had significantly lower values of PIX
than benign lesions. The greatest differences were observed be-
tween BCC and the other two tissue types (normal and benign
lesions).
Depth of measurement did not appear to have a large effect
on results. Values of indexes on individual lesions would change
from one depth to another, but the relative relationships between
tissue types tend to remain the same. Little change in the average
value of the index was observed with increasing depth for MIX
or IMIX. The average index value rose slightly with increasing
depth for PIX, but generally rose uniformly for each group of
measurements.
While these results are encouraging, there is a greater overlap
between measured values than one would like for differentiation
of tissue type using electrical impedance. It is possible to dis-
criminate malignant tumors from benign lesions in the dataset
with a sensitivity around 90% using MIX, PIX, or IMIX, but
specificity must fall to around 50% to achieve this result. One
must consider, however, that every lesion measurement also in-
cludes normal skin. A lesion 2 mm in diameter constitutes only
about 4% of the total area beneath the probe when using the
outer source electrode. The rest of the tissue is normal skin.
Even when measurements are made with only the inner source
electrode, a great deal of normal tissue is likely to be included
in the measurement. Differences in electrical impedance be-
tween BCC and benign lesions might be obscured by this normal
tissue. If our hypothesis that normal skin is interfering with the
measurement of small lesions is true, one would expect differ-
ences in measurements to increase with increasing lesion size.
To test this hypothesis, measured index values at all five depths
were plotted as a function of lesion size as shown in Fig. 4. The
straight lines in each plot show the best straight-line approxima-
tion of index values as a function of size. While index values for
BCC show a clear decrease with size, values for benign lesions
change only slightly. Values for benign lesions may have only
changed slightly because normal skin and benign lesions have
similar index values.
IV. DISCUSSION
Results comparing BCC and normal skin were similar to re-
sults reported by Emtestam et al. for lesions 10 mm or greater
in size. Emtestam et al. also found a significant decrease in the
value of MIX or IMIX over BCC compared with normal skin.
Both studies showed few significant differences in the value of
RIX. A small discrepancy between the studies occurs with PIX,
where Emtestam et al. found no significant differences and our
study found significant differences at some depths. The simi-
larity in the outcomes of the two studies confirms our results and
shows that the conclusions of Emtestam et al. may also apply to
much smaller lesions.
In addition to confirmation of results of Emtestam et al. for
smaller lesions, our study also found significant differences be-
tween BCC and benign lesions for the indexes MIX, IMIX, and
PIX. Some statistically significant differences were found be-
tween normal skin and benign lesions for PIX. Values of MIX,
IMIX, and PIX were generally statistically smaller over BCC
than over normal skin or benign lesions. No significant differ-
ences were found for RIX.
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TABLE IV
MEAN AND STANDARD DEVIATION OF IMPEDANCE MEASURES
OVER NORMAL SKIN
Measurements were made on normal skin adjacent to BCC and benign lesions. Prob-
ability of similarity was calculated between these two groups.
Results are for depth 1. Similar results were found at other depths.
Explanation of the pathophysiological basis for these differ-
ences requires further study. Differences may result because
BCC tumors may be better irrigated by the local blood supply
than normal skin or benign lesions or because the stratum
corneum is thinner or better hydrated over BCC. The nuclei of
BCC cells also tend to be larger and the intercellular spaces
smaller than for cells from normal skin. These structural
differences appear to cause measurable differences in the
impedance of the tissue as a function of frequency [13]. Malig-
nant cell membranes also tend to have different electrochemical
properties than normal cells, which may also contribute to the
observed differences.
Previous studies have shown that the electrical impedance of
the skin is affected by age and measurement site [7]. Because the
average age of the group with BCC and the group with benign
lesions differed and because more BCC occurred on the head
and neck than benign lesions, we investigated the possibility that
differences in electrical impedance were caused by these differ-
ences rather than differences in the lesions themselves. General
changes in impedance with age or site should be reflected in the
measures of normal skin adjacent to the lesion. Table IV shows
the average value of the indexes on the normal skin adjacent to
the lesion for the group of patients with BCC and for the group
with benign lesions. The table also shows the statistical proba-
bility of similarity between these measures. The average value
of the indexes were similar for both groups, indicating that dif-
ferences found earlier between BCC and benign lesions were
caused by the lesions and not by more general differences be-
tween the groups.
While results are encouraging, further studies are needed to
confirm the potential diagnostic value of electrical impedance
for BCC. Significant differences were found between the
impedance of BCC and normal skin or benign lesions, but the
separation was not large enough to facilitate clear identification
of the lesion based only on impedance. However, the probe
size was quite large compared with the size of most lesions
and the normal skin included in each measurement probably
obscured clear differentiation of results. Poor contact between
the electrode and the skin and differences between individuals
and measurement sites may have also obscured results. The
fact that separation of the measures increases with lesion size
indicates that better results might be obtained using a smaller or
more sophisticated probe or using more sophisticated analysis
techniques that take into account the combined measurement
of normal skin and the suspect lesion.
From a clinical point of view, the usefulness of this tech-
nology would come primarily from a separation of benign and
malignant lesions. It is a weakness of this study that different
types of benign lesions are considered as a group, resulting in
an inhomogeneous group of benign lesions. The small number
for each benign diagnosis does not allow exploration of the fea-
sibility of separation of different benign diagnoses. This is an
important topic for future work.
It should be mentioned that diagnosis of malignancies using
electrical impedance has some potential limitations, as pre-
sented in this paper. First, it is not clear that the results obtained
for BCC can be generalized to other types of malignancy.
For BCC, the tissue has a consistency that is considerably
different from normal skin and this difference is not as great
for other types of malignancies or even some variants of BCC
not investigated here. Application to other malignancies needs
to be studied. Second, because the probe must be placed on a
suspected area, this technique does not resolve the problem of
lesions that are completely overlooked at a screening session.
On the other hand, it does appear that electrical impedance may
provide additional diagnostic information to the physician that
is not available from visual images, allowing them to verify or
improve their diagnosis of suspect lesions. Improvements to the
probe and to analysis techniques should substantially improve
the diagnostic potential of electrical impedance, making it a
useful companion to visual diagnosis of malignant lesions and
possibly assisting in differentiation of uncommon variants of
BCC or improvements in detecting BCC recurrence.
Visual diagnosis of the skin, by itself, is an imperfect means
of detecting skin cancer. An inexpensive, rapid, and noninva-
sive diagnostic tool that could help the clinician identify cancer
has obvious benefits. Results from this study show that electrical
impedance may provide the basis for such a tool. The study sug-
gests impedance may be used to separate BCC from benign le-
sions that have a similar appearance to BCC, even when tumor
size is relatively small. Accurate methods of performing this dif-
ferentiation may require a smaller or more sophisticated probe
or a more sophisticated analysis technique than was used in this
paper. Additional studies are needed to demonstrate the diag-
nostic potential of electrical impedance for BCC and other types
of skin cancer.
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